Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
O-linked N-acetylglucosamine hydrolase (OGA) is an enzyme responsible for removing the monosaccharide modification *O*-linked β-N-acetylglucosamine (*O*-GlcNAc) from serine and threonine residues of nuclear, cytoplasmic, and mitochondrial proteins. This process is a key part of the dynamic post-translational modification cycle called *O*-GlcNAcylation. The balance between OGA and OGT (O-GlcNAc transferase) is crucial for normal cell function, and dysregulation has been linked to various diseases.
Inhibition of O-GlcNAc hydrolysis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on O-linked N-acetylglucosamine hydrolase (OGA).